טוען...
Chemokine, vascular and therapeutic effects of combination Simvastatin and BMSC treatment of stroke
We investigated the additive therapeutic effect that combination treatment of stroke with sub-therapeutic doses of Simvastatin, a HMG-CoA reductase inhibitor, and bone marrow stromal cells (BMSCs). Rats were administered Simvastatin (0.5 mg/kg), BMSCs (1×10(6)) or combination Simvastatin with BMSCs...
שמור ב:
| Main Authors: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2009
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2748847/ https://ncbi.nlm.nih.gov/pubmed/19591934 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nbd.2009.06.012 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|